Heterodisomy means both copies of a chromosome came from one grandparent, while isodisomy means the two copies are identical duplicates of just one homolog. The distinction matters because heterodisomy can unmask a recessive disease carried on the shared grandparental chromosome, whereas isodisomy does so and also converts every heterozygous locus on that chromosome into homozygosity. Both patterns arise from errors in meiosis or early mitosis, and both are detected by comparing parental genotypes against the child's.
The meiotic mechanics behind each pattern
Meiosis I separates homologous chromosomes; meiosis II separates sister chromatids. Where the error happens controls which form of uniparental disomy (UPD) you get. A failure of homolog separation at meiosis I, followed by fertilization and trisomy rescue, typically leaves two different homologs from the same grandparent. That is heterodisomy: the child has both of the grandparent's chromosome versions.
Meiosis II errors behave differently. When sister chromatids fail to separate, the resulting gamete carries two identical chromatids. After trisomy rescue or monosomy rescue, the child ends up with two copies of the same chromatid. That is isodisomy: the two copies are molecularly identical along their length, except at regions where crossing over occurred during prophase I.
The crossover detail is the counterintuitive part. Nearly every real isodisomy carries stretches of heterodisomy near the telomeres, because meiotic recombination swaps segments between homologs before segregation. A "pure" isodisomy chromosome is rare. Conversely, heterodisomy often contains short isodisomic segments where recombination made the two copies identical. Segmental UPD is the modern framing: each chromosome is a mosaic, and the labels describe the dominant pattern rather than a binary state.
Quantified context: why the distinction changes disease risk
The clinical stakes come down to homozygosity. In heterodisomy, the child inherits two different alleles at most loci, so a recessive mutation on one grandparental chromosome is usually paired with a normal allele on the other. In isodisomy, the same allele appears twice, so a single recessive variant becomes fully expressed. This is why isodisomy behaves like consanguinity confined to one chromosome.
Two numbers frame the risk. First, isodisomy converts heterozygous loci to homozygous across the affected chromosome, so carrier status for any recessive gene on that chromosome becomes disease. Second, imprinting disorders depend on parent of origin rather than identity, so heterodisomy and isodisomy carry the same imprinting risk when the whole chromosome is uniparental. The pattern predicts recessive disease; parent of origin predicts imprinting disease.
Reporting frequency is low but not negligible. UPD is estimated at roughly 1 in 3,500 live births across all chromosomes in population studies, but these figures vary widely by chromosome and detection method. The best-supported examples are chromosomes 6, 7, 11, 14, and 15, where imprinting effects make UPD clinically visible. For non-imprinted chromosomes, most UPD is found incidentally during trio testing rather than through a targeted search. Chromosome 15 maternal UPD causes Prader-Willi syndrome; paternal UPD causes Angelman syndrome. Those diagnoses hinge on parent of origin, not on hetero- versus isodisomy.
Where the boundary blurs: edge cases and segmental patterns
Real chromosomes rarely fit either label cleanly. Recombination during meiosis I means an isodisomic chromosome almost always has heterodisomic terminal segments. A trisomy rescue event can also produce mixed patterns: two copies from one parent may be identical in the middle and divergent at the ends. Clinical labs therefore report mitotic recombination maps rather than a single verdict.
A second edge case is mitotic UPD. If a postzygotic error duplicates one homolog and loses the other, the result is isodisomy with no meiotic crossing over at all. This produces long runs of homozygosity and can cause segmental disease even when the chromosome is not fully uniparental. Mitotic recombination is also the mechanism behind some cases of mosaic isodisomy, where only a fraction of cells carry the pattern.
A third edge case is confined placental mosaicism. Trisomy rescue in the placenta but not the fetus can produce apparent UPD in one tissue and normal biparental inheritance in another. Sampling site matters, and a normal blood result does not exclude UPD in another tissue.
Red flag: a recessive disease appears in a child with only one carrier parent and no family history. Red flag: severe intrauterine growth restriction with a normal karyotype and no obvious cause. Red flag: an imprinting disorder phenotype without the expected methylation abnormality. Red flag: long contiguous runs of homozygosity on a single chromosome in trio testing.
Misconceptions worth correcting
The most common misconception is that heterodisomy is harmless. It is not, because imprinting genes ignore allele identity and respond only to parent of origin. A child with heterodisomic chromosome 15 from the mother still develops Prader-Willi syndrome. The pattern tells you about recessive risk, not about imprinting risk.
A second misconception treats isodisomy as equivalent to consanguinity. It is not. Consanguinity affects the whole genome; isodisomy affects one chromosome. The recessive risk is real but confined, and the rest of the genome remains heterozygous. This matters for counseling and for interpreting homozygosity runs.
A third misconception is that UPD always means disease. Most UPD on non-imprinted chromosomes is clinically silent. Detection usually happens because a trio panel was ordered for another reason, and the finding is incidental. The pattern is a mechanism, not a diagnosis.
Comparison of the two patterns
| Feature | Heterodisomy | Isodisomy |
|---|---|---|
| Origin of the two copies | Two different homologs from one grandparent | Two identical chromatids from one homolog |
| Typical meiotic error | Meiosis I nondisjunction | Meiosis II nondisjunction or mitotic duplication |
| Heterozygosity along chromosome | Mostly heterozygous | Mostly homozygous |
| Recessive disease risk | Low unless a segment is isodisomic | High for recessive genes on that chromosome |
| Imprinting disorder risk | Present if parent of origin is abnormal | Present if parent of origin is abnormal |
| Detection signal | Parental genotypes match two grandparental haplotypes | Long runs of homozygosity on one chromosome |
| Clinical action | Imprinting testing if chromosome is imprinted | Recessive carrier screen and imprinting testing |
Timeline of detection and interpretation
| Stage | What happens | Typical timing |
|---|---|---|
| Meiotic error | Nondisjunction or precocious separation | At gamete formation |
| Fertilization | Aneuploid zygote forms | Conception |
| Trisomy or monosomy rescue | One chromosome is lost, leaving UPD | Early cleavage divisions |
| Prenatal screening | Aneuploidy screen flags a trisomy | First or second trimester |
| Diagnostic testing | Karyotype, microarray, or trio sequencing | After abnormal screen or at birth |
| UPD confirmation | Parental genotypes compared to child's | Weeks after sample collection |
| Clinical interpretation | Imprinting and recessive risk assessed | After confirmation |
Practical actions for clinicians and families
Start with parent-of-origin testing when the chromosome is imprinted. Chromosomes 6, 7, 11, 14, and 15 carry the best-documented imprinting regions, and methylation analysis answers the imprinting question directly. Do not rely on hetero- versus isodisomy labels to rule imprinting in or out.
Order trio testing when UPD is suspected. Comparing child genotypes to both parents separates heterodisomy from isodisomy and maps segmental boundaries. A single proband sample cannot distinguish the two patterns reliably.
Run a recessive carrier screen on the shared grandparental chromosome when isodisomy is confirmed. The goal is to identify any pathogenic variant that has become homozygous. Targeted sequencing of the affected chromosome is more efficient than whole-genome sequencing for this purpose.
Counsel on recurrence risk separately from diagnosis. Meiotic nondisjunction carries a low recurrence risk in most families, but Robertsonian translocations and other structural rearrangements raise it. Karyotype both parents when a structural cause is suspected.
Document the sampling site. Confined placental mosaicism can produce discordant results across tissues. If blood is normal but the phenotype persists, consider a second tissue.
Limits of what current testing can conclude
UPD detection depends on informative markers. Regions with low heterozygosity, common in certain populations, can make hetero- versus isodisomy assignment ambiguous. Segmental UPD is often undercalled because standard microarrays do not resolve small isodisomic blocks.
Imprinting testing covers a limited set of loci. A normal methylation result at the tested regions does not exclude an uncharacterized imprinting effect elsewhere on the chromosome. The biology of imprinting is still incompletely mapped.
Finally, the clinical literature on UPD is dominated by case reports and small cohorts, so frequency estimates carry wide uncertainty. The mechanism is stable and well understood; the population numbers are not. Treat any quoted prevalence as an order-of-magnitude guide rather than a precise rate, and let trio data and methylation results drive the clinical decision.